Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis

Abstract Background: Children with familial hypercholesterolemia may develop early endothelial damage leading to a high risk for the development of cardiovascular disease (CVD). Statins have been shown to be effective in lowering LDL cholesterol levels and cardiovascular events in adults. The effect of statin treatment in the pediatric population is not clearly demonstrated. Objective: To systematically review the literature to evaluate the effects of different statins and dosages in total cholesterol levels in children and adolescents with familial hypercholesterolemia. We also aimed to evaluate statin safety in this group. Methods: PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO and LILACS databases, were searched for articles published from inception until February 2016. Two independent reviewers performed the quality assessment of the included studies. We performed a meta-analysis with random effects and inverse variance, and subgroup analyses were performed. Results: Ten trials involving a total of 1543 patients met the inclusion criteria. Our study showed reductions in cholesterol levels according to the intensity of statin doses (high, intermediate and low): (-104.61 mg/dl, -67.60 mg/dl, -56.96 mg/dl) and in the low-density lipoprotein cholesterol level: [-105.03 mg/dl (95% CI -115.76, -94.30), I2 19.2%], [-67.85 mg/dl (95% CI -83.36, -52.35), I2 99.8%], [-58.97 mg/dl (95% CI -67.83, -50.11), I2 93.8%. The duration of statin therapy in the studies ranged from 8 to 104 weeks, precluding conclusions about long-term effects. Conclusion: Statin treatment is efficient in lowering lipids in children with FH. There is need of large, long-term and randomized controlled trials to establish the long-term safety of statins.

Saved in:
Bibliographic Details
Main Authors: Radaelli,Graciane, Sausen,Grasiele, Cesa,Claudia Ciceri, Santos,Francisco de Souza, Portal,Vera Lucia, Neyeloff,Jeruza Lavanholi, Pellanda,Lucia Campos
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cardiologia - SBC 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018001800810
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0066-782X2018001800810
record_format ojs
spelling oai:scielo:S0066-782X20180018008102018-11-27Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-AnalysisRadaelli,GracianeSausen,GrasieleCesa,Claudia CiceriSantos,Francisco de SouzaPortal,Vera LuciaNeyeloff,Jeruza LavanholiPellanda,Lucia Campos Statins Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypercholesterolemia Type II/genetic Children Meta-Analysis Abstract Background: Children with familial hypercholesterolemia may develop early endothelial damage leading to a high risk for the development of cardiovascular disease (CVD). Statins have been shown to be effective in lowering LDL cholesterol levels and cardiovascular events in adults. The effect of statin treatment in the pediatric population is not clearly demonstrated. Objective: To systematically review the literature to evaluate the effects of different statins and dosages in total cholesterol levels in children and adolescents with familial hypercholesterolemia. We also aimed to evaluate statin safety in this group. Methods: PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO and LILACS databases, were searched for articles published from inception until February 2016. Two independent reviewers performed the quality assessment of the included studies. We performed a meta-analysis with random effects and inverse variance, and subgroup analyses were performed. Results: Ten trials involving a total of 1543 patients met the inclusion criteria. Our study showed reductions in cholesterol levels according to the intensity of statin doses (high, intermediate and low): (-104.61 mg/dl, -67.60 mg/dl, -56.96 mg/dl) and in the low-density lipoprotein cholesterol level: [-105.03 mg/dl (95% CI -115.76, -94.30), I2 19.2%], [-67.85 mg/dl (95% CI -83.36, -52.35), I2 99.8%], [-58.97 mg/dl (95% CI -67.83, -50.11), I2 93.8%. The duration of statin therapy in the studies ranged from 8 to 104 weeks, precluding conclusions about long-term effects. Conclusion: Statin treatment is efficient in lowering lipids in children with FH. There is need of large, long-term and randomized controlled trials to establish the long-term safety of statins.info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.111 n.6 20182018-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018001800810en10.5935/abc.20180180
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Radaelli,Graciane
Sausen,Grasiele
Cesa,Claudia Ciceri
Santos,Francisco de Souza
Portal,Vera Lucia
Neyeloff,Jeruza Lavanholi
Pellanda,Lucia Campos
spellingShingle Radaelli,Graciane
Sausen,Grasiele
Cesa,Claudia Ciceri
Santos,Francisco de Souza
Portal,Vera Lucia
Neyeloff,Jeruza Lavanholi
Pellanda,Lucia Campos
Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
author_facet Radaelli,Graciane
Sausen,Grasiele
Cesa,Claudia Ciceri
Santos,Francisco de Souza
Portal,Vera Lucia
Neyeloff,Jeruza Lavanholi
Pellanda,Lucia Campos
author_sort Radaelli,Graciane
title Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
title_short Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
title_full Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
title_fullStr Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
title_full_unstemmed Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis
title_sort statin treatments and dosages in children with familial hypercholesterolemia: meta-analysis
description Abstract Background: Children with familial hypercholesterolemia may develop early endothelial damage leading to a high risk for the development of cardiovascular disease (CVD). Statins have been shown to be effective in lowering LDL cholesterol levels and cardiovascular events in adults. The effect of statin treatment in the pediatric population is not clearly demonstrated. Objective: To systematically review the literature to evaluate the effects of different statins and dosages in total cholesterol levels in children and adolescents with familial hypercholesterolemia. We also aimed to evaluate statin safety in this group. Methods: PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO and LILACS databases, were searched for articles published from inception until February 2016. Two independent reviewers performed the quality assessment of the included studies. We performed a meta-analysis with random effects and inverse variance, and subgroup analyses were performed. Results: Ten trials involving a total of 1543 patients met the inclusion criteria. Our study showed reductions in cholesterol levels according to the intensity of statin doses (high, intermediate and low): (-104.61 mg/dl, -67.60 mg/dl, -56.96 mg/dl) and in the low-density lipoprotein cholesterol level: [-105.03 mg/dl (95% CI -115.76, -94.30), I2 19.2%], [-67.85 mg/dl (95% CI -83.36, -52.35), I2 99.8%], [-58.97 mg/dl (95% CI -67.83, -50.11), I2 93.8%. The duration of statin therapy in the studies ranged from 8 to 104 weeks, precluding conclusions about long-term effects. Conclusion: Statin treatment is efficient in lowering lipids in children with FH. There is need of large, long-term and randomized controlled trials to establish the long-term safety of statins.
publisher Sociedade Brasileira de Cardiologia - SBC
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018001800810
work_keys_str_mv AT radaelligraciane statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
AT sausengrasiele statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
AT cesaclaudiaciceri statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
AT santosfranciscodesouza statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
AT portalveralucia statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
AT neyeloffjeruzalavanholi statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
AT pellandaluciacampos statintreatmentsanddosagesinchildrenwithfamilialhypercholesterolemiametaanalysis
_version_ 1756382104271192064